Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Bruce L. Levine(University of Pennsylvania), Marcelo C. Pasquini(Medical College of Wisconsin), John E. Connolly(Parker Institute for Cancer Immunotherapy), David L. Porter(University of Pennsylvania), Michael P. Gustafson(Mayo Clinic Hospital), Jaap Jan Boelens(Memorial Sloan Kettering Cancer Center), Edwin M. Horwitz(Emory University), Stephan A. Grupp(Children's Hospital of Philadelphia), Marcela V. Maus(Harvard University), Frederick L. Locke(Moffitt Cancer Center), Fabio Ciceri(Vita-Salute San Raffaele University), Annalisa Ruggeri(Vita-Salute San Raffaele University), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Helen E. Heslop(Baylor College of Medicine), Crystal L. Mackall(Parker Institute for Cancer Immunotherapy), Carl H. June(Parker Institute for Cancer Immunotherapy), Anna M. Sureda(Institut d'Investigació Biomédica de Bellvitge), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center)
Cited by 195Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis